{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:30Z","timestamp":1787027010565,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Desmoid tumors (DT) is a rare soft tissue tumor classified as a borderline neoplasm. It exhibits locally aggressive growth and is prone to postoperative recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We reported the first case of adolescent pelvic DT ureteral fistula, and report the patient's all progress of diagnosis and treatment. A recurrent pelvic DT in an adolescent female patient who initially underwent surgical resection but experienced recurrence, was effectively treated with sorafenib. Later, however, the patient's tumor changed from solid to cystic solid mixed, increasing in size, and the patient developed right hydronephrosis and hydroureter. Patients who underwent right sided antegrade pyelography were diagnosed with right sided ureteral desmoid tumor fistula and urinary fistula-related pseudocysts. Following treatment with right sided percutaneous nephrostomy, their condition improved, with resolution of right sided hydronephrosis and hydroureter, as well as partial shrinkage of the cystic component.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DT can rarely result in the development of DT-ureteral fistulas. For patients with DT responsive to medical therapy, physicians should closely monitor tumor progression and pay attention to its invasion of adjacent organs and potential complications. Physicians need to balance therapeutic efficacy and quality of life when making treatment strategies for young patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2025.1573732","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T01:25:53Z","timestamp":1745889953000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Recurrent desmoid tumors with ureteric fistula: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"LongDi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaJie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ajcp\/77.6.665","article-title":"The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population","volume":"77","author":"Reitamo","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"B3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3348\/jksr.2016.75.5.410","article-title":"A case of a desmoid tumor with an ureterotumoral fistula detected on renal scintigraphy","volume":"75","author":"Yoo","year":"2016","journal-title":"J Korean Soc Radiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0090-4295(96)00367-6","article-title":"Desmoid tumor-ureteral fistula in Gardner\u2019s syndrome","volume":"49","author":"Richard","year":"1997","journal-title":"Urology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejrad.2005.12.036","article-title":"Inoperable aggressive mesenteric fibromatosis with ureteric fistula. Case report and literature review","volume":"59","author":"Lath","year":"2006","journal-title":"Eur J Radiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/RLU.0000000000000951","article-title":"Renographic demonstration of desmoid tumor-ureteral fistula","volume":"41","author":"Kim","year":"2016","journal-title":"Clin Nucl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1200\/JCO.1999.17.1.158","article-title":"Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy","volume":"17","author":"Ballo","year":"1999","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1245\/s10434-012-2634-6","article-title":"Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients","volume":"19","author":"Peng","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1097\/SAP.0000000000003381","article-title":"The role of reconstruction on desmoid tumor recurrence: a systematic review and technical considerations","volume":"90","author":"Meade","year":"2023","journal-title":"Ann Plast Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1200\/JCO.2010.33.5489","article-title":"Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation","volume":"29","author":"Salas","year":"2011","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/bjs.10477","article-title":"Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis","volume":"104","author":"Janssen","year":"2017","journal-title":"Br J Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1200\/JCO.2003.05.150","article-title":"Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution","volume":"21","author":"Gronchi","year":"2003","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/annonc\/mdx323","article-title":"An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between sarcoma PAtients EuroNet (SPAEN) and European organization for research and treatment of cancer (EORTC)\/soft tissue and bone sarcoma group (STBSG)","volume":"28","author":"Kasper","year":"2017","journal-title":"Ann Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejca.2014.11.019","article-title":"Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients","volume":"51","author":"Colombo","year":"2015","journal-title":"Eur J Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1245\/s10434-009-0586-2","article-title":"Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment","volume":"16","author":"Fiore","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ejso.2007.06.006","article-title":"Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients","volume":"34","author":"Bonvalot","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1073\/pnas.102657399","article-title":"\u03b2-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds","volume":"99","author":"Cheon","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2559.2007.02619.x","article-title":"Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis","volume":"50","author":"Gebert","year":"2007","journal-title":"Histopathology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2350\/10-07-0866-OA.1","article-title":"Analysis of \u03b2-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis","volume":"15","author":"Bo","year":"2012","journal-title":"Pediatr Dev Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2352-4642(17)30045-7","article-title":"The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series","volume":"1","author":"Orbach","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/s0002-9610(05)81243-7","article-title":"Problems in diagnosis and management of desmoid tumors","volume":"159","author":"Lopez","year":"1990","journal-title":"Am J Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.suc.2022.05.005","article-title":"The evolving management of desmoid fibromatosis","volume":"102","author":"Prendergast","year":"2022","journal-title":"Surg Clin North Am"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa1805052","article-title":"Sorafenib for advanced and refractory desmoid tumors","volume":"379","author":"Gounder","year":"2018","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/DDDT.S443107","article-title":"Understanding sorafenib-induced cardiovascular toxicity: mechanisms and treatment implications","volume":"18","author":"Li","year":"2024","journal-title":"Drug Des Devel Ther"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1573732\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T01:25:56Z","timestamp":1745889956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1573732\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":24,"alternative-id":["10.3389\/fped.2025.1573732"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1573732","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"article-number":"1573732"}}